Tata Nifty MidSmall Healthcare Index Fund Regular IDCW NAV today
AMFI: 152562ISIN: INF277KA1BE8MUTF_IN: TATA_NIFT_MIDS_1J17E6LTata Mutual FundIndex funds
NAV ₹13.7647
NAV for 23 Oct 2026. Declared once a day.
- Fund sizeAssets under management. The money the fund manages for all its investors, across every plan, at the end of the month.
- ₹221 CrSep 2026
- Expense ratioTotal expense ratio. What the fund charges each year as a share of the money invested, taken out of the NAV every day, so the returns shown are already after it.
- 1.14%14 Oct 2026
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought.
- 0.25%if sold within 15 days
- P/EP/E. What the fund pays for each rupee of yearly profit its companies earn: the total value of its shares divided by those companies' last four quarters of profit, each in proportion to what the fund holds. The profit leaves out one-off items (exceptional items and businesses sold or demerged), so one company's one-off gain cannot make the fund look cheap. A loss-making company lowers the profit. Shown when at least 80% of the fund's shares are counted.
- 39.630 Sep 2026
- Risk levelRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very HighAug 2026
- HoldingsHoldings. The number of different securities in the fund's latest monthly portfolio: shares, bonds, money market paper and units of other funds, not cash, overnight lending or futures.
- 3030 Sep 2026
- Offer openedNew fund offer opened. The day the fund's new fund offer opened for investors to apply; units are allotted when it closes.
- 8 Apr 2024
Tata Nifty MidSmall Healthcare Index Fund returns
Read from the regular plan's growth option: an IDCW plan's NAV falls by every payout, so it carries no return of its own
Over each window to 23 Oct 2026
| Over | ReturnTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back. |
|---|---|---|
| 1 week | −3.36% | −3.34% |
| 1 month | −10.47% | −10.40% |
| 3 months | −5.56% | −5.29% |
| 6 months | +5.34% | +5.96% |
| 1 year | +6.57% | +7.81% |
| 3 years | Needs 3 years | – |
₹10,000 put in on 30 Apr 2024 is ₹13,656 at the NAV of 23 Oct 2026Growth of ₹10,000. What ₹10,000 put in at the NAV of the first day would be worth at the latest NAV, after the fund's expenses and before tax and any exit load.Over a year and longer, a return is the yearly rate. Benchmark: Nifty MidSmall Healthcare TRI, over the same days as the fund.
At the month end, 30 Sep 2026
| Over | FundTrailing return. The change in NAV from the start date to the latest NAV; over a year and longer, the yearly rate that would compound to the same change (CAGR). | BenchmarkBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer. |
|---|---|---|
| 1 year | +17.21% | +18.60% |
| Since launch | +17.29% | +18.94% |
Benchmark: Nifty MidSmall Healthcare TRI. Both as the fund house states them for the month.
Return in each calendar year
- Fund, Regular GrowthCalendar year return. The change in NAV from the last NAV of one year to the last NAV of the next.
- Nifty MidSmall Healthcare TRIBenchmark return. The change in the benchmark index's total return level over the same dates as the fund's return, as a yearly rate over a year and longer.
- Loss
Tata Nifty MidSmall Healthcare Index Fund SIP returns
₹10,000 on the 1st of every month, valued at the NAV of 23 Oct 2026
| Period | InvestedAmount invested. ₹10,000 on the 1st of every month, or the next day the fund priced, added up over the period. | Value todayValue today. What the units bought by every instalment are worth at the latest NAV. | Invested against value today | SIP returnSIP return (XIRR). The yearly rate that, applied to each monthly instalment from the day it was invested, gives the value of all the units today. | After stamp dutySIP return after stamp duty. The same SIP return with stamp duty of 0.005% taken from every instalment since 1 Jul 2020, so ₹10,000 buys ₹9,999.50 of units. | Stamp dutyStamp duty paid. The stamp duty on all the instalments, in rupees: 0.005% of each purchase made since 1 Jul 2020. |
|---|---|---|---|---|---|---|
| 1 year12 instalments | ₹1,20,000 | ₹1,23,328₹1,23,322 after stamp duty | +5.41% | +5.40% | ₹6 | |
| Since Apr 202430 instalments | ₹3,00,000 | ₹3,33,019₹3,33,002 after stamp duty | +8.45% | +8.44% | ₹15 |
3 years: Needs 3 years of history.
From the Regular Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Rolling returns
Per cent a year, every window from 30 Apr 2024 to 23 Oct 2026
Lowest to highestAverage
LowestLowest rolling return. The worst yearly return of any window of this length in the fund's history, one window starting on each day it priced.AverageAverage rolling return. The average of the yearly returns of every window of this length in the fund's history.HighestHighest rolling return. The best yearly return of any window of this length in the fund's history.Ended higherWindows that ended higher. The share of all the windows of this length in which the NAV ended above where it started.
1 year368 windows−2.6%+10.9%+25.0%93.2%
3 yearsNeeds 4 years of history
From the Regular Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Tracking error
Against Nifty MidSmall Healthcare TRI, as on 30 Sep 2026.
Against its index, by window
| Measure | Regular, this plan | Direct |
|---|---|---|
| Tracking errorTracking error. How much an index fund's daily returns differed from its index's, stated as a yearly figure. | 0.06% | 0.05% |
| Difference, 1 yearTracking difference. The index fund's return less its index's return over the same period; the fund's costs make it negative. | −1.39 pts | −0.68 pts |
| Difference since launch | −1.65 pts | −0.88 pts |
Difference: the fund's return less the index's, in percentage points.
Tata Nifty MidSmall Healthcare Index Fund expense ratio and exit load
Per cent of the money invested, a year. Each month shows its last day filed; the parts were redefined from Apr 2026.
- Regular over directDirect and regular plan cost gap. The regular plan's expense ratio less the direct plan's: what buying through a distributor costs each year, since both plans own the same portfolio.
- 0.56 ptsA year, on 14 Oct 2026
- Direct, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 0.57%Over the last 29 days filed
- Regular, 30-day averageExpense ratio, 30-day average. The total expense ratio averaged over the last 30 days the fund filed it, which evens out the day-to-day moves in brokerage and levies.
- 1.13%Over the last 29 days filed
Total expense ratio, month by month
- Regular plan
- Direct plan
Direct plan highest 0.59%, Aug 2026.Direct plan lowest 0.34%, Sep 2024.
What the expense ratio is made of
| Part | Direct | Regular |
|---|---|---|
| Base expense ratioBase expense ratio. The part of the expense ratio that pays the fund house and the distributor, before brokerage, transaction costs, levies and GST. | 0.37% | 0.90% |
| Brokerage | 0.02% | 0.02% |
| Transaction costs | None | None |
| Statutory levies | 0.19% | 0.22% |
Per cent of assets a year, filed for 22 Oct 2026. The parts add up to that day's total.
Buying and selling
- Exit loadExit load. A charge, as a share of the amount redeemed, on units sold before a set period has passed since they were bought.
- 0.25% of the applicable NAV, if redeemed on or before 15 days from the date of allotment.
- Lump-sum purchases
- Accepted
- Minimum investmentMinimum investment. The smallest amount the plan accepts for a first purchase.
- ₹5,000
- Minimum top-up
- ₹1,000
- Minimum redemption
- ₹500
- SIP
- Accepted
- STP, transfers to another fund
- Not accepted
- SWP, regular withdrawals
- Accepted
- Switches
- Accepted
- Lock-inLock-in. The time after each purchase during which those units cannot be sold.
- None
- SIP minimum
- 100.00/1,000.00/1,000.00/1,500.00/100.00/100.00
- SIP instalments, at least
- 12 Instalments/6 instalments/6 instalments/4 instalments/12 instalments/12 instalments
- SIP dates
- Any day/Any day/Any day/Any day/Monday-Friday/All Business Days
As listed for this plan on 24 Oct 2026.
Tata Nifty MidSmall Healthcare Index Fund AUM
₹ crore, every plan of the fund together.
- Average assetsAverage assets under management. The money the fund managed, averaged over every day of the quarter, added up across its plans.
- ₹210 CrQuarter to Sep 2026
- In the direct plansShare of assets in the direct plans. The direct plans' average assets for the quarter as a percentage of the fund's total; the rest is in the regular plans, bought through distributors.
- 71.8%Of the quarter's average
Average assets by quarter, by plan
- Regular plans
- Direct plans
The latest quarter is the largest since the quarter to Jun 2024.
Assets at each month end
The latest month end is the highest since Apr 2025.Lowest ₹135 Cr, Apr 2025.
Tata Nifty MidSmall Healthcare Index Fund portfolio
Portfolio disclosed for 30 Sep 2026.
Holdings on 30 Sep 2026
| Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month. | Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | Held since. The first month end of the fund's current run of holding this position; marked "or earlier" where that month is the fund's first portfolio on record or the first after a gap in its portfolios. | |||
|---|---|---|---|---|---|
| Laurus LabsPharmaceuticals & Biotechnology | Mid cap171st | 11.84% | 26.12 | 1,31,927 | Apr 2024or earlier |
| LupinPharmaceuticals & Biotechnology | Mid cap105th | 7.57% | 16.70 | 82,281 | Apr 2024or earlier |
| Aurobindo PharmaPharmaceuticals & Biotechnology | Mid cap138th | 7.09% | 15.65 | 93,615 | Apr 2024or earlier |
| Fortis HealthcareHealthcare Services | Mid cap156th | 6.16% | 13.59 | 1,76,499 | Apr 2024or earlier |
| Glenmark PharmaceuticalsPharmaceuticals & Biotechnology | Mid cap176th | 5.40% | 11.91 | 51,001 | Apr 2024or earlier |
| Alkem LaboratoriesPharmaceuticals & Biotechnology | Mid cap164th | 4.78% | 10.55 | 20,425 | Apr 2024or earlier |
| Mankind PharmaPharmaceuticals & Biotechnology | Mid cap119th | 4.36% | 9.61 | 38,387 | Apr 2024or earlier |
| IPCA LaboratoriesPharmaceuticals & Biotechnology | Mid cap229th | 4.11% | 9.07 | 47,059 | Apr 2024or earlier |
| BioconPharmaceuticals & Biotechnology | Mid cap173rd | 3.96% | 8.74 | 2,36,076 | Apr 2024or earlier |
| Gland PharmaPharmaceuticals & Biotechnology | Small cap261st | 3.55% | 7.83 | 26,996 | Apr 2024or earlier |
| Sai Life SciencesPharmaceuticals & Biotechnology | Small cap329th | 3.24% | 7.14 | 46,851 | Mar 2026 |
| Krishna Institute of Medical SciencesHealthcare Services | Small cap285th | 3.06% | 6.75 | 90,397 | Apr 2024or earlier |
| Aster DM Quality CareHealthcare Services | Mid cap244th | 2.86% | 6.31 | 90,546 | Apr 2024or earlier |
| Neuland LaboratoriesPharmaceuticals & Biotechnology | Small cap356th | 2.83% | 6.24 | 2,921 | Mar 2025 |
| WockhardtPharmaceuticals & Biotechnology | Small cap311th | 2.68% | 5.92 | 27,982 | Sep 2025 |
Weight is per cent of the fund's net assets; value in ₹ crore.
Cash and receivables on 30 Sep 2026
| Weight in the fund. The holding's market value on the portfolio date as a share of the fund's net assets. | ||
|---|---|---|
| NET CURRENT LIABILITIES | −0.27% | −0.54 |
| REPO | 0.13% | 0.28 |
| MARGIN MONEY DEPOSITS TOTAL | 0.00% | 0.00 |
Weight is per cent of the fund's net assets; value in ₹ crore.
- Largest holdingLargest holding. The share of the fund in its single largest position, cash and futures not counted as positions.
- 11.84%Laurus Labs
- Top 5 holdingsTop 5 holdings. The share of the fund held in its five largest positions.
- 38.06%
- Top 10 holdingsTop 10 holdings. The share of the fund held in its ten largest positions.
- 58.82%
- Effective holdingsEffective number of holdings. The number of equal-sized positions that would be as concentrated as the fund's actual weights.
- 20.2Taken over 100.14% of the fund
Asset allocation
Asset allocation. What the fund owns, by kind of asset, each as a share of its net assets; futures and options are shown beside it, not in it, since they are contracts rather than assets bought.- Indian shares100.14%
- Cash and receivables−0.14%
Per cent of the fund's net assets.
Large, mid and small cap
Large, mid and small cap. Companies ranked by average market value over six months: the first 100 are large cap, the next 150 mid cap, the rest small cap, by the list in force for the portfolio's month.- Large capNone
- Mid cap67.82%
- Small cap32.18%
Per cent of the fund's Indian shares. By the list for the six months to Jun 2026.
Sector allocation
Sector weight. The fund's shares grouped by the business each company is in, less the futures sold on them, each group as a share of the fund's net assets.1sector
- Healthcare100.14%
Per cent of the fund's net assets, less the futures sold on its shares, Sep 2026.
Sector allocation month by month
| 13 months | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare30 companies | 100.14% | 100.13% | 100.03% | 100.06% | 100.09% | 100.08% | 99.86% | 101.41% | 100.01% | 100.03% | 100.00% | 100.08% |
Per cent of the fund's net assets, less the futures sold on its shares, at each month end, Oct 2025 to Sep 2026; the line runs from Sep 2025.
Bought and sold
Sep 2026 against Aug 2026, position by position.
Positions changed, month by month
- New
- Added
- Trimmed
- Sold out
- New positionsNew positions. Holdings in this month's portfolio that were not in the month before.
- 11.42% of the fund
- Sold outSold out. Holdings in last month's portfolio that are gone from this one, other than a bond or deposit repaid on its due date.
- 11.07% of the fund before
- Added toAdded to. Holdings with more units than the month before. Where the fund states no units, a weight that rose by more than a tenth.
- 29
- TrimmedTrimmed. Holdings with fewer units than the month before. Where the fund states no units, a weight that fell by more than a tenth.
- 0
- UnchangedUnchanged. Holdings with the same number of units as the month before. Their weight can still move with the price.
- 0
- Traded at leastTraded at least. The smaller of the weight bought in new positions and the weight sold out of old ones, cash left out: the least the fund must have bought and sold in the month.
- 1.07%
- Weight that movedWeight that moved. Half the sum of every position's change in weight between the two month ends, new and sold positions included; price moves alone raise it.
- 3.88%
Changes in Sep 2026
| What changed. New: not held the month before. Added or trimmed: more or fewer units than the month before, or, where no units are stated, a weight that moved by more than a tenth. Sold out: held the month before, gone now. Matured: a bond or deposit whose repayment date fell between the two portfolios, so it was repaid rather than sold (one sold in its last days reads the same). | Change in weight. The holding's weight this month less its weight the month before, in percentage points; a price move alone changes it. | ||||
|---|---|---|---|---|---|
| Anthem Biosciences | New | 1.42% | 0.00% | +1.42 pts | +36,551 |
| Pfizer | Sold out | – | 1.07% | −1.07 pts | −5,001 |
| Fortis Healthcare | Added | 6.16% | 7.12% | −0.96 pts | +4,521 |
| Laurus Labs | Added | 11.84% | 11.22% | +0.62 pts | +3,525 |
| Biocon | Added | 3.96% | 4.43% | −0.47 pts | +625 |
| Lupin | Added | 7.57% | 8.01% | −0.44 pts | +2,136 |
| Wockhardt | Added | 2.68% | 2.34% | +0.34 pts | +729 |
| Ajanta Pharma | Added | 2.53% | 2.29% | +0.24 pts | +1,544 |
| Mankind Pharma | Added | 4.36% | 4.13% | +0.23 pts | +1,025 |
| Glenmark Pharmaceuticals | Added | 5.40% | 5.62% | −0.22 pts | +1,311 |
| Sai Life Sciences | Added | 3.24% | 3.03% | +0.21 pts | +1,318 |
| Neuland Laboratories | Added | 2.83% | 2.99% | −0.16 pts | +75 |
| Abbott India | Added | 2.17% | 2.03% | +0.14 pts | +46 |
| Acutaas Chemicals | Added | 2.61% | 2.47% | +0.14 pts | +463 |
| GlaxoSmithKline Pharmaceuticals | Added | 1.76% | 1.90% | −0.14 pts | +365 |
Weights are per cent of the fund's net assets; a change in weight is in percentage points.
Holdings month by month
| Holding | Oct 25 | Nov 25 | Dec 25 | Jan 26 | Feb 26 | Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 Laurus Labs | 6.91%Added | 7.44%Added | 8.00%Cut | 7.33%Cut | 7.80%Added | 7.34%Cut | 7.57%Cut | 8.82%Cut | 9.36%Added | 10.79%Added | 11.22%Added | 11.84%Added |
 Lupin | 8.86%Added | 9.35%Added | 9.51%Cut | 10.20%Cut | 10.41%Added | 10.67%Cut | 9.88%Cut | 9.15%Cut | 9.30%Added | 8.96%Added | 8.01%Added | 7.57%Added |
 Aurobindo Pharma | 5.94%Added | 6.37%Added | 6.15%Cut | 6.60%Cut | 6.37%Added | 6.93%Cut | 6.86%Cut | 6.64%Cut | 6.99%Added | 6.68%Added | 7.16%Added | 7.09%Added |
 Fortis Healthcare | 9.94%Added | 8.89%Added | 8.56%Cut | 8.67%Cut | 9.17%Added | 7.88%Cut | 8.50%Cut | 8.05%Cut | 7.90%Added | 7.52%Added | 7.12%Added | 6.16%Added |
 Glenmark Pharmaceuticals | 5.31%Added | 5.44%Added | 5.70%Cut | 5.93%Cut | 6.00%Added | 6.10%Cut | 6.40%Cut | 5.70%Cut | 5.26%Added | 5.14%Added | 5.62%Added | 5.40%Added |
 Alkem Laboratories | 5.78%Added | 5.94%Added | 5.99%Added | 6.49%Cut | 6.16%Added | 5.90%Cut | 5.58%Cut | 5.35%Cut | 5.17%Added | 5.14%Added | 4.70%Added | 4.78%Added |
 Mankind Pharma | 5.03%Added | 4.73%Added | 4.62%Cut | 4.69%Cut | 4.74%Added | 4.32%Cut | 4.49%Cut | 4.47%Cut | 4.56%Added | 4.27%Added | 4.13%Added | 4.36%Added |
 IPCA Laboratories | 3.29%Added | 3.75%Added | 3.67%Cut | 3.99%Cut | 3.97%Added | 4.23%Cut | 3.76%Cut | 3.52%Cut | 3.74%Added | 3.71%Added | 4.13%Added | 4.11%Added |
 Biocon | 4.17%Added | 4.44%Added | 4.40%Cut | 4.30%Cut | 5.19%Added | 4.90%Cut | 4.54%Cut | 5.09%Cut | 4.73%Added | 4.64%Added | 4.43%Added | 3.96%Added |
 Gland Pharma | 2.86%Added | 2.60%Added | 2.55%Cut | 2.87%Cut | 2.71%Added | 2.57%Cut | 2.46%Cut | 2.98%Cut | 3.15%Added | 3.05%Added | 3.46%Added | 3.55%Added |
 Sai Life Sciences | – | – | – | – | – | 2.54%Bought | 2.60%Cut | 2.66%Cut | 2.69%Added | 2.77%Added | 3.03%Added | 3.24%Added |
 Krishna Institute of Medical Sciences | 3.31%Added | 3.13%Added | 2.79%Cut | 2.91%Cut | 3.43%Added | 2.92%Cut | 2.91%Cut | 3.12%Cut | 3.19%Added | 3.19%Added | 2.95%Added | 3.06%Added |
 Aster DM Quality Care | 2.86%Added | 2.79%Added | 2.67%Added | 2.51%Cut | 2.84%Added | 3.23%Added | 3.14%Cut | 3.07%Cut | 3.15%Added | 3.18%Added | 2.88%Added | 2.86%Added |
 Neuland Laboratories | 2.63%Added | 2.75%Added | 2.42%Cut | 2.22%Cut | 2.05%Added | 1.97%Cut | 2.29%Cut | 2.45%Cut | 2.54%Added | 2.51%Added | 2.99%Added | 2.83%Added |
 Wockhardt | 1.97%Added | 1.89%Added | 2.22%Cut | 2.23%Cut | 2.10%Added | 1.85%Cut | 2.04%Cut | 2.79%Cut | 2.54%Added | 2.47%Added | 2.34%Added | 2.68%Added |
Per cent of the fund's net assets at each month end, Oct 2025 to Sep 2026. Under it, the change on the fund's previous month. "After a gap" is a holding after a month with no portfolio on record, so when it was bought is not known; "Not filed" is one gone across such a gap.
Portfolio turnover, per cent of assets a year
- TurnoverPortfolio turnover. How much of the portfolio the fund bought or sold over the last year, as a share of its assets, as the fund house states it.
Highest 33.0% in Apr 2026
Risk ratios
NAV to 23 Oct 2026
How much the NAV moves
Standard deviationStandard deviation. How far the fund's monthly returns spread around their average, stated as a yearly figure: the wider the spread, the more the NAV moves.14.97%
Downside deviationDownside deviation. Standard deviation counting only the months in which the fund lost money, stated as a yearly figure.8.23%
Sharpe ratioSharpe ratio. The monthly return above the 91-day Treasury bill yield, divided by its standard deviation and stated for a year: the extra return for each unit of movement in the NAV.0.79
Sortino ratioSortino ratio. The monthly return above the 91-day Treasury bill yield, divided by how far it fell below that yield and stated for a year: the extra return for each unit of movement on the way down.1.30
From the Regular Growth plan's NAV, since an IDCW plan's NAV falls by each payout.
Against Nifty MidSmall Healthcare TRI
BetaBeta. How much the fund's monthly return moved for each 1% move in its benchmark: 1 moves with it, below 1 moves less.1.00
AlphaAlpha. The yearly return the fund made beyond what its beta to the benchmark accounts for.−1.38 pts
R-squaredR-squared. The share of the fund's monthly movement that its benchmark's movement explains, from 0 to 100.100.0
CorrelationCorrelation. How closely the fund's monthly returns moved in step with its benchmark's, from minus 1 (always opposite) to 1 (always together).1.00
Upside captureUpside capture. The fund's return in the months its benchmark rose, as a percentage of the benchmark's return in those months.97.5%
Downside captureDownside capture. The fund's return in the months its benchmark fell, as a percentage of the benchmark's fall in those months.Needs 6 falling months
Largest falls
| Largest over | FallLargest fall. The biggest drop in NAV from a high to the low that followed, before the NAV went back above that high. | High on | Low on | Back at the highBack at the high. The first day the NAV closed at or above the high it had fallen from. |
|---|---|---|---|---|
| 1 year | −10.47% | 23 Sep 2026 | 23 Oct 2026 | Not yet |
| Since Apr 2024 | −17.62% | 7 Jan 2025 | 28 Feb 2025 | 15 Jul 2025 |
Risk level by month
| Months | FundRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month. | BenchmarkBenchmark's risk level. The riskometer level of the fund's benchmark index for the same month, on the same six-step scale as the fund's own. |
|---|---|---|
| Apr 2024 to Aug 202629 months | Very High | Very HighNifty MidSmall Healthcare TRI |
The riskometer at each month end, the fund's and its benchmark's. A month with none on record is left out.
Tata Nifty MidSmall Healthcare Index Fund managers
Managers now
| Manager | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | Portfolio changed after the handover. How much of the portfolio was different three months after the manager took over: half the sum of every holding's change in weight, with each side's holdings scaled to add up to 100 so a move into cash does not count. | Portfolio changed before the handover. The same measure over the three months before the manager took over, since portfolios change anyway. | Assets the manager runs. The latest monthly size of every fund the manager runs now, added up; a fund run with others counts in full for each of its managers, and the line under it counts only the funds they run alone. | ||
|---|---|---|---|---|---|---|---|---|
| Nitin SharmaPrimary | Jul 2025 | +9.62%a year | +10.94% | −1.31 pts | 17.8% | 5.0% | 25 | ₹20,718 Cr |
| Rakesh PrajapatiAssistant Fund Manager | Dec 2024 | +6.94%a year | +8.20% | −1.26 pts | 7.6% | 6.5% | 23 | ₹9,414 Cr |
Returns are the regular plan's growth NAV, from the day each took over to the latest NAV, beside the benchmark over the same days.
Other funds they run
| Fund | Return in the manager's time. The change in the plan's NAV from the day the manager took the fund over to the latest NAV; past a year, the yearly rate that would compound to the same change. | Benchmark over the same days. The change in the fund's benchmark index over the same days as the manager's return, worked out the same way, with the dividends of the index's companies added back. | Difference from the benchmark. The fund's return in the manager's time less its benchmark's over the same days, in percentage points. | ||
|---|---|---|---|---|---|
| Tata Gold Exchange Traded FundNitin Sharma | Jul 2025 | +35.70%a year | – | – | ₹6,138 Cr |
| Tata Silver Exchange Traded FundNitin Sharma | Jul 2025 | +65.92%a year | – | – | ₹5,166 Cr |
| Tata Nifty 50 Index FundNitin Sharma | Jul 2025 | −6.81%a year | −6.28% | −0.53 pts | ₹1,627 Cr |
| Tata Gold ETF Fund of FundNitin Sharma | Mar 2026 | −8.60%over 221 days | – | – | ₹1,534 Cr |
| Tata Nifty Midcap 150 Momentum 50 Index FundNitin Sharma | Jul 2025 | −4.95%a year | −3.61% | −1.34 pts | ₹1,206 Cr |
| Tata Silver ETF Fund of FundNitin Sharma | Mar 2026 | −19.18%over 221 days | – | – | ₹1,056 Cr |
| Tata Nifty Capital Markets Index FundNitin Sharma | Jul 2025 | +7.83%a year | +9.16% | −1.33 pts | ₹964 Cr |
| Tata Nifty 50 Exchange Traded FundNitin Sharma | Jul 2025 | −6.31%a year | −6.28% | −0.04 pts | ₹674 Cr |
| Tata BSE Sensex Index FundNitin Sharma | Jul 2025 | −7.97%a year | – | – | ₹364 Cr |
| Tata Nifty Midcap 150 Index FundNitin Sharma | Jul 2025 | −1.51%a year | −0.10% | −1.41 pts | ₹318 Cr |
Up to ten funds a manager, largest first. Returns are the regular plan's.
Portfolio overlap
Funds holding the most of the same securities, by weight.
Closest funds in the category
| Portfolio overlap. The share of the two funds' portfolios that is the same: for every holding they share, the smaller of its two weights, added up. | Shared holdings. The number of securities both funds hold, cash and futures left out. | |
|---|---|---|
| Motilal Oswal Nifty MidSmall Healthcare Index FundMotilal Oswal Mutual Fund | 99.96% | 30 |
| ICICI Prudential Nifty Pharma Index FundICICI Prudential Mutual Fund | 43.09% | 14 |
| Bandhan BSE Healthcare Index FundBandhan Mutual Fund | 40.75% | 30 |
| DSP Nifty Healthcare Index FundDSP Mutual Fund | 36.88% | 12 |
| Edelweiss Msci India Domestic & World Healthcare 45 Index FundEdelweiss Mutual Fund | 27.58% | 17 |
| Kotak Nifty Smallcap 50 Index FundKotak Mahindra Mutual Fund | 18.12% | 10 |
| Kotak Nifty Midcap 150 Momentum 50 Index FundKotak Mahindra Mutual Fund | 17.33% | 7 |
| Edelweiss Nifty Midcap150 Momentum 50 Index FundEdelweiss Mutual Fund | 17.30% | 7 |
| Tata Nifty Midcap 150 Momentum 50 Index FundTata Mutual Fund | 17.29% | 7 |
| Motilal Oswal BSE Midcap 150 Momentum 30 Index FundMotilal Oswal Mutual Fund | 16.40% | 5 |
Portfolios for Sep 2026. Overlap is per cent of the portfolio the two funds hold in common.
Changes to the fund
Newest first.
2026
- 1 AprExpenseExpense ratio stated under the new rules: a base ratio, with brokerage, levies and GST on top
Fund details
Objective
The investment objective of the scheme is to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The scheme does not assure or guarantee any returns
Asset allocation
- Securities covered by Nifty MidSmall HealthcareIndex (95-100),Debt & Money Market Instruments^ including units of Mutual Funds (0-5). The scheme can invest residual portion of upto 5% in other liquid instruments** in addition to the existing instruments mentioned in the offer documents.
**Other liquid instruments include cash, bank deposits with Scheduled Commercial Banks, Government Securities, Treasury bills, Repo on Government securities and any other instruments as specified by the SEBI.
Type of scheme
An open-ended scheme replicating/tracking Nifty MidSmall Healthcare Index (TRI).
- BenchmarkBenchmark. The index the fund house chose to measure the fund against, in its total return form, with dividends added back.
- Nifty MidSmall Healthcare Index (TRI)
- Risk level at launchRiskometer. The fund's own risk label on SEBI's six-step scale, from Low to Very High, set from what the fund holds and reviewed every month.
- Very High
- New fund offer
- 8 Apr 2024 to 22 Apr 2024
- Open for sale again
- 30 Apr 2024
- Price at the offer
- ₹10 a unit
- Minimum at the offer
- ₹5,000
Plans and codes
| Plan | AMFI code | ISIN | MUTF_IN | First NAV |
|---|---|---|---|---|
| Direct Growth | 152564 | INF277KA1BG3 | TATA_NIFT_MIDS_H2AX60 | 30 Apr 2024 |
| Regular Growth | 152567 | INF277KA1BD0 | TATA_NIFT_MIDS_1VYW2S3 | 30 Apr 2024 |
| Direct IDCW | 152565 | INF277KA1BH1 | TATA_NIFT_MIDS_15C0UWU | 30 Apr 2024 |
| Regular IDCW | 152562 | INF277KA1BE8 | TATA_NIFT_MIDS_1J17E6L | 30 Apr 2024 |
This fund
- Scheme information document (opens in a new tab)The fund's objective, terms, costs and risks in full
Factsheet
- Factsheet September 2026 (opens in a new tab)Tata Mutual Fund, Sep 2026
Statement of additional information
- SAI Tata Mutual Fund (opens in a new tab)Tata Mutual Fund, Oct 2026
Annual report
- Annual Report Annexures for F.Y. 2025-2026 (opens in a new tab)Tata Mutual Fund, Mar 2026
- Annual Report for Debt and Cash Schemes (opens in a new tab)Tata Mutual Fund, Mar 2026
- Annual Report for Equity Schemes (opens in a new tab)Tata Mutual Fund, Mar 2026
- Abridged Annual Report for Debt Schemes (opens in a new tab)Tata Mutual Fund, Mar 2026
Riskometer disclosure
- Risk Parameters in respect of Mid Cap and Small Cap equity schemes for FY-2026-27 (opens in a new tab)Tata Mutual Fund, Sep 2026
Portfolio overlap disclosure
- Portfolio Overlap Report as on September 2026 (opens in a new tab)Tata Mutual Fund, Sep 2026